AEGiS-SAPA: Mozambicans need ARVs South African Press AssociationImportant note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu
DonateNow


Mozambicans need ARVs

South African Press Association - May 10, 2007


More than 300,000 people living with HIV/Aids need anti-retroviral treatment in Mozambique, but only a fraction of them are actually receiving the drugs, national media reported on Thursday.

Cesar Mufanequico, co-ordinator for the Anti-Retroviral Treatment Access Movement, told Radio Mozambique that throughout the country "only 44,000 HIV-positive persons" out of an estimated 300,000 were receiving antiretroviral treatment.

He said the government's expectation was to increase the number of anti-retroviral treatment recipients to 90,000 by the end of 2006.

Mufanequico was speaking ahead of the global week on access to antiretroviral treatment, which will be marked from May 20 to 26.

He urged the government to accelerate its Aids-combating strategy by increasing the number of people receiving anti-retroviral treatment.

UNAIDS estimates that at least 230,000 are in need of antiretroviral drugs throughout the country.

"The government failed to meet a target of reaching 55,000 people - 3500 of them children - with treatment by the end of 2006, but there have been some improvements," said a UNAIDS report published in April.

The Mozambican government expects to receive this year more than $300m from the Global Fund to Fight Aids, Tuberculosis and Malaria, the World Bank, and the Clinton Foundation.

In September 2006, the United States government, through the President's Emergency Plan for Aids Relief, donated &94m in response to Mozambique's Aids appeal.

Mozambique's Aids infection rate is pegged at more than 16 percent and new infections reported each year continue to strain efforts to fight the epidemic in this impoverished country of more than 19 million people.


070510
SA070501


Copyright © 2007 - South African Press Association. Reproduction of this article (other than one copy for personal reference) must be cleared through the South African Press Association, Cotswold House, Greenacres Office Park, Cnr. Victory & Rustenburg Roads, VICTORY PARK, PO BOX 7766, JOHANNESBURG, 2000; Fax No: +27 11 782-1587/8, Tel No: +27 11 782-1600.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .